XK and influenza: MVA vectors expressing various combinations of NP, M1, HA and NA have been evaluated in animal models [25]–[34], and phase I clinical studies of an MVA vector expressing NP and M1 indicate that this approach might be efficacious to prevent influenza infection in humans [35], [36].